They found tumour uptake of >10%ID/g at 24 and 48 h after administration of 89Zr-transferrin, also labelled using the iron-binding siderophore desferrioxamine (DFO) as a metal ion chelator rather than relying on the transferrin itself to bind to the 89Zr4+ ion. This evidence concerns the gene TF and neoplasm.